Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Forecast, 2015 – 2021

Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Forecast, 2015 – 2021

Comments Off on Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Forecast, 2015 – 2021

According to the report, the global veterinary vaccines market accounted for around USD 12.10 billion in 2015 and is expected to reach approximately USD 20.60 billion by 2021, growing at a CAGR of around 9.3% between 2016 and 2021.Vaccination is one of the most used applications of modern biotechnology to prevent chronic bacterial, viral and protozoal diseases. Veterinary vaccines are eco-friendly and used to increase animal welfare by preventing the death of animals, loss of dairy products and monetary loss of owners. Recently highly effective third generation vaccine against rabies virus has been developed with the help of recombinant technology. With the use of the vaccine, we can avoid the problem of antibiotic and drug resistance by the microorganism.




According to the report, the global veterinary vaccines market accounted for around USD 12.10 billion in 2015 and is expected to reach approximately USD 20.60 billion by 2021, growing at a CAGR of around 9.3% between 2016 and 2021.

Vaccination is the administration of vaccines in the body to stimulate immunity against specific microorganism to prevent life-threatening diseases. Vaccines are biological preparations produced from living microorganisms to enhance immune system against disease. Vaccines are classified as prophylactic vaccines and therapeutic vaccines. Prophylactic vaccines are used to prevent diseases while therapeutic vaccines are used to treat diseases. Vaccines are composed of either whole disease-causing microorganism or its disease-causing components. Several types of vaccines are present in veterinary vaccines market such as live or inactivated form. The main aim of veterinary vaccine market is to improve the health of animals and birds as well as to reduce the risk of transmission of diseases from animals to human.

Veterinary vaccine market is propelled by new emerging technological advances in vaccine development, improving food security and increasing awareness of animal care. In addition, veterinary vaccine market is increased by the continuous development of drug resistance by the microorganism and new emerging animal diseases. Moreover, an increasing number of veterinary research centers and colleges are also responsible for the growth of veterinary vaccines market. Furthermore, the market is generating more revenue by the addition of new veterinary vaccines against viral, bacterial and protozoal diseases by leading companies. On the other hand, high maintenance cost for vaccine storage and bioethical issues are projected to affect the growth of veterinary vaccine market in near future. However, increasing prevalence of animal diseases and investments by government in developing countries are projected to act as an opportunity for the growth of global veterinary vaccine market.

Global Veterinary Vaccines Market

Based on the application the market of the veterinary vaccine is segmented into livestock vaccines and companion vaccines.  Livestock vaccine segment is further sub-segmented into poultry, porcine and aquaculture while companion vaccines are classified into equine, canine and feline. Among the two segments analyzed, in 2015, livestock vaccines accounted for the larger share of the market about 62% of global veterinary vaccine market.

Veterinary vaccines market is segmented on the basis of technology as attenuated vaccines, DNA Vaccines, inactivated vaccines, toxoid vaccines and recombinant vaccines.  Among the technology type segments, attenuated vaccines market accounts for the highest market share. In the forecast period, DNA vaccines market is expected to show noticeable growth due to new emerging innovative technology for vaccine production.

Based on the geography the veterinary vaccines market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. On the basis of revenue, North America, and Europe is dominating the veterinary vaccines market.  In North America, the U.S. held the largest market in veterinary vaccine market in 2015. Asia-Pacific is expected to show high growth due to increasing trade and consumption of meat. While the Middle East and Africa, and Latin America are also expected to show noticeable growth during the forecast period.

Key operating players operating in veterinary vaccines market are Heska Corporation, Zoetis Inc., Ceva Santé Animale Inc., Merck Animal Health, Sanofi (Merial Animal Health), Boehringer Ingelheim GmbH, Eli Lilly and Company (Elanco Animal Health), Virbac, and Bayer AG, Bimeda.

Chapter1. Introduction

  • 1.1. Report Description And Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

Chapter2. Executive Summary

  • 2.1. Global veterinary vaccine market, 2015 – 2021 (USD Billion)
  • 2.2. Global veterinary vaccine market: Snapshot

Chapter3. Veterinary vaccine market – Market Dynamics

  • 3.1. Introduction
  • 3.2. Value Chain Analysis
  • 3.3. Market Drivers
    • 3.3.1. Global veterinary vaccine market Drivers: Impact Analysis
    • 3.3.2. New emerging technological advances in vaccine development and increasing awareness of animal care
    • 3.3.3. Continuous development of drug resistance by microorganism and new emerging animal diseases
  • 3.4. Market Restraints
    • 3.4.1. Global veterinary vaccine market Restraints: Impact Analysis
    • 3.4.2. High competition
  • 3.5. Opportunities
    • 3.5.1. Increasing investment by government of developing countries.
  • 3.6. Porter’s Five Forces Analysis
    • 3.6.1. Bargaining Power Of Suppliers
    • 3.6.2. Bargaining Power Of Buyers
    • 3.6.3. Threat From New Entrants
    • 3.6.4. Threat From New Substitutes
    • 3.6.5. Degree Of Competition
  • 3.7. Market Attractiveness Analysis
    • 3.7.1. Market Attractiveness Analysis, by Application segment
    • 3.7.2. Market Attractiveness Analysis, by Technology segment
    • 3.7.3. Market Attractiveness Analysis, By Regional Segment

Chapter4. Global veterinary vaccine market – Competitive Landscape

  • 4.1. Company Market Share, 2014 (Subject To Data Availability)
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Source Launch
    • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
    • 4.2.4. Research and Development, Product And Regional Expansion.
  • 4.3. Product Portfolio
  • 4.4. Patent Analysis (2011-2016)
    • 4.4.1. Patent Trend
    • 4.4.2. Patent Share By Company
    • 4.4.3. By Region

Chapter5. Global veterinary vaccine market – Product type Analysis

  • 5.1. Global veterinary vaccine market: Product type Segment Overview
    • 5.1.1. Global veterinary vaccine market Revenue Share, by Product type Segment, 2015 And 2021
  • 5.2. Livestock vaccines
    • 5.2.1. Global veterinary vaccine market for livestock vaccines , 2015 – 2021 (USD Billion)
  • 5.3. Companion vaccines
    • 5.3.1. Global veterinary vaccine market for Companion vaccine, 2015 – 2021 (USD Billion)

Chapter6. Global veterinary vaccine market – Technology type Analysis

  • 6.1. Global veterinary vaccine market: Technology type Segment Overview
    • 6.1.1. Global veterinary vaccine market Revenue Share, By Technology type Segment, 2015 – 2021
  • 6.2. Attenuated vaccines
    • 6.2.1. Global veterinary vaccine market for Attenuated vaccines, 2015 – 2021 (USD Billion)
  • 6.3. DNA Vaccines
    • 6.3.1. Global veterinary vaccine market for DNA vaccines, 2015 – 2021 (USD Billion)
  • 6.4. Inactivated vaccines
    • 6.4.1. Global veterinary vaccine market for inactivated vaccines, 2015 – 2021 (USD Billion)
  • 6.5. Toxoid vaccines
    • 6.5.1. Global veterinary vaccine market for toxoid vaccines, 2015 – 2021 (USD Billion)
  • 6.6. Recombinant vaccines
    • 6.6.1. Global veterinary vaccine market for recombinant vaccines, 2015 – 2021 (USD Billion)

Chapter7. Global veterinary vaccine market – Regional Segment Analysis

  • 7.1. Global veterinary vaccine market: Regional Overview
    • 7.1.1. Global veterinary vaccine market Revenue Share, By Region, 2014 And 2020
  • 7.2. North America
    • 7.2.1. North America veterinary vaccine market Revenue, by Product type classification, 2015 – 2021 , (USD Billion)
    • 7.2.2. North America veterinary vaccine market Revenue, by Technology type 2015 – 2021 , (USD Billion)
    • 7.2.3. U.S.
      • 7.2.3.1. U.S. veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.2.3.2. U.S. veterinary vaccine market revenue, by Technology type application 2015 – 2021 , (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe veterinary vaccine market revenue, by Product type, 2015 – 2021 (USD Billion)
    • 7.3.2. Europe veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
    • 7.3.3. U.K.
      • 7.3.3.1. U.K. veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.3.3.2. U.K. veterinary vaccine market Revenue, by Technology type 2015 – 2021 , (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. U.K. veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.3.4.2. U.K. veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
    • 7.3.5. Germany
      • 7.3.5.1. Germany veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.3.5.2. Germany veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific veterinary vaccine market revenue, by Product type, 2015 – 2021 (USD Billion)
    • 7.4.2. Asia Pacific veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
    • 7.4.3. China
      • 7.4.3.1. China veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.4.3.2. China veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
    • 7.4.4. Japan
      • 7.4.4.1. Japan veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.4.4.2. Japan veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
    • 7.4.5. India
      • 7.4.5.1. India veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.4.5.2. India veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Veterinary vaccine market Revenue, by Product type, 2015 – 2021 (USD Billion)
    • 7.5.2. Latin America veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
    • 7.5.3. Brazil
      • 7.5.3.1. Brazil veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
      • 7.5.3.2. Brazil veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)

Chapter8. Company Profile

  • 8.1. Teva Pharmaceutical Industries Ltd.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategy
    • 8.1.5. Recent Developments
  • 8.2. Novartis International AG.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. Mylan N.V.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategy
    • 8.3.5. Recent Developments
  • 8.4. Abbott Healthcare Pvt Ltd.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
    • 8.4.5. Recent Developments
  • 8.5. Actavis pharmaceuticals Overview
    • 8.5.1. Financials
    • 8.5.2. Product Portfolio
    • 8.5.3. Business Strategy
    • 8.5.4. Recent Developments
  • 8.6. Sun Pharmaceutical Industries Limited
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategy
    • 8.6.5. Recent Developments

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Veterinary vaccine market Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Veterinary vaccine market: Market Attractiveness Analysis, by Product type segment
6. Global Veterinary vaccine market: Market Attractiveness Analysis, by Therapeutic application Segment
7. Global Veterinary vaccine market: Market Attractiveness Analysis, by Regional Segment
8. Company Market Share Analysis, 2015 and 2021
9. Global Veterinary vaccine market Revenue Share by Product type segment, 2015 and 2021
10. Global veterinary vaccine market for livestock vaccines , 2015 – 2021 (USD Billion)
11. Global veterinary vaccine market for Companion vaccine, 2015 – 2021 (USD Billion)
12. Global veterinary vaccine market Revenue Share, By Technology type Segment, 2015 – 2021
13. Global veterinary vaccine market for Attenuated vaccines, 2015 – 2021 (USD Billion)
14. Global veterinary vaccine market for DNA vaccines, 2015 – 2021 (USD Billion)
15. Global veterinary vaccine market for toxoid vaccines, 2015 – 2021 (USD Billion)
16. Global veterinary vaccine market for inactivated vaccines, 2015 – 2021 (USD Billion)
17. Global veterinary vaccine market for recombinant vaccines, 2015 – 2021 (USD Billion)
18. North America veterinary vaccine market Revenue, by Product type classification, 2015 – 2021 , (USD Billion)
19. North America veterinary vaccine market Revenue, by Technology type 2015 – 2021 , (USD Billion)
20. U.S. veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
21. U.S. veterinary vaccine market revenue, by Technology type application 2015 – 2021 , (USD Billion)
22. Europe veterinary vaccine market revenue, by Product type, 2015 – 2021 (USD Billion)
23. Europe veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
24. U.K. veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
25. U.K. veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
26. Germany veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
27. Germany veterinary vaccine market revenue, by Technology type 2015 – 2021 , (USD Billion)
28. Asia Pacific veterinary vaccine market revenue, by Product type, 2015 – 2021 (USD Billion)
29. Asia Pacific veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
30. China veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
31. China veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
32. Japan veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
33. Japan veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
34. India veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
35. India veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
36. Latin America Veterinary vaccine market Revenue, by Product type, 2015 – 2021 (USD Billion)
37. Latin America veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)
38. Brazil veterinary vaccine market revenue, by Product type, 2015 – 2021 , (USD Billion)
39. Brazil veterinary vaccine market revenue, by Technology type Technology type 2015 – 2021 , (USD Billion)


List of Tables

1. Veterinary vaccine market: Market Snapshot
2. Drivers Of Global Veterinary vaccine market: Impact Analysis
3. Restraints Of Global Veterinary vaccine market: Impact Analysis
4. North America veterinary vaccine market Revenue, by Product type classification, 2015 – 2021 , (USD Billion)
5. North America veterinary vaccine market Revenue, by Technology type 2015 – 2021 , (USD Billion)
6. Europe veterinary vaccine market Revenue, by Product type , 2015 – 2021 (USD Billion)
7. Europe veterinary vaccine market Revenue, by Technology type2015 – 2021 , (USD Billion)
8. Asia Pacific veterinary vaccine market Revenue, by Product type , 2015 – 2021 (USD Billion)
9. Asia Pacific veterinary vaccine market Revenue, by Technology type 2015 – 2021 , (USD Billion)
10. Latin America veterinary vaccine market Revenue, by Product type , 2015 – 2021 (USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account